Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

Lavendustin A (CAS 125697-92-9)

5.0(1)
Write a reviewAsk a question

Alternate Names:
5-Amino-[(N-2,5-dihydroxybenzyl)-N′-2-hydroxybenzyl]salicylic acid;RG14355
Application:
Lavendustin A is a selective and potent inhibitor of the receptor tyrosine kinase
CAS Number:
125697-92-9
Purity:
≥95%
Molecular Weight:
381.38
Molecular Formula:
C21H19NO6
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Lavendustin A selectively and potently inhibits EGFR (epidermal growth factor receptor) tyrosine kinase. The chemical has been observed to bind to a site on the kinase that is different from the peptide substrate and ATP binding sites. Lavendustin A is an inhibitor of c-Src.


Lavendustin A (CAS 125697-92-9) References

  1. Inhibition of atrial wall stretch-induced cardiac hormone secretion by lavendustin A, a potent tyrosine kinase inhibitor.  |  Taskinen, P., et al. 1999. Endocrinology. 140: 4198-207. PMID: 10465292
  2. Protein tyrosine kinase activity of lavendustin A and the phytoestrogen genistein on progesterone synthesis in cultured rat ovarian cells.  |  Whitehead, SA. and Lacey, M. 2000. Fertil Steril. 73: 613-9. PMID: 10689022
  3. Acute and chronic effects of genistein, tyrphostin and lavendustin A on steroid synthesis in luteinized human granulosa cells.  |  Whitehead, SA., et al. 2002. Hum Reprod. 17: 589-94. PMID: 11870108
  4. Synthesis and investigation of conformationally restricted analogues of lavendustin A as cytotoxic inhibitors of tubulin polymerization.  |  Mu, F., et al. 2002. J Med Chem. 45: 4774-85. PMID: 12361405
  5. Structure-activity relationship studies on a novel class of antiproliferative agents derived from Lavendustin A. Part I: Ring A modifications.  |  Nussbaumer, P. and Winiski, AP. 2008. Bioorg Med Chem. 16: 7552-60. PMID: 18678497
  6. Inhibition of tyrosine kinase and epidermal growth factor receptor internalization by lavendustin A methyl ester in cultured A431 cells.  |  Onoda, T., et al. 1990. Drugs Exp Clin Res. 16: 249-53. PMID: 2086161
  7. Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus.  |  Onoda, T., et al. 1989. J Nat Prod. 52: 1252-7. PMID: 2614420
  8. Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A.  |  Hu, DE. and Fan, TP. 1995. Br J Pharmacol. 114: 262-8. PMID: 7533611
  9. Novel antiproliferative agents derived from lavendustin A.  |  Nussbaumer, P., et al. 1994. J Med Chem. 37: 4079-84. PMID: 7990108
  10. Non-amine based analogues of lavendustin A as protein-tyrosine kinase inhibitors.  |  Smyth, MS., et al. 1993. J Med Chem. 36: 3010-4. PMID: 8105084
  11. Tyrosine kinase inhibitors, herbimycin A and lavendustin A, block formation of long-term potentiation in the dentate gyrus in vivo.  |  Abe, K. and Saito, H. 1993. Brain Res. 621: 167-70. PMID: 8221070
  12. SDZ 281-977: a modified partial structure of lavendustin A that exerts potent and selective antiproliferative activities in vitro and in vivo.  |  Cammisuli, S., et al. 1996. Int J Cancer. 65: 351-9. PMID: 8575857
  13. Chloride efflux during the progesterone-initiated human sperm acrosome reaction is inhibited by lavendustin A, a tyrosine kinase inhibitor.  |  Meizel, S. and Turner, KO. 1996. J Androl. 17: 327-30. PMID: 8889693

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Lavendustin A, 1 mg

sc-200539
1 mg
$116.00

Lavendustin A, 5 mg

sc-200539A
5 mg
$456.00